- Home
- AWX vs KPRX Comparison
AWX vs KPRX Comparison
Compare AWX & KPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWX
- KPRX
- Stock Information
- Founded
- AWX 1998
- KPRX 1998
- Country
- AWX United States
- KPRX United States
- Employees
- AWX N/A
- KPRX N/A
- Industry
- AWX Environmental Services
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AWX Utilities
- KPRX Health Care
- Exchange
- AWX Nasdaq
- KPRX Nasdaq
- Market Cap
- AWX 9.7M
- KPRX 9.2M
- IPO Year
- AWX 1998
- KPRX N/A
- Fundamental
- Price
- AWX $2.46
- KPRX $2.65
- Analyst Decision
- AWX
- KPRX Strong Buy
- Analyst Count
- AWX 0
- KPRX 1
- Target Price
- AWX N/A
- KPRX $10.00
- AVG Volume (30 Days)
- AWX 2.7K
- KPRX 26.7K
- Earning Date
- AWX 11-07-2025
- KPRX 11-07-2025
- Dividend Yield
- AWX N/A
- KPRX N/A
- EPS Growth
- AWX 306.94
- KPRX N/A
- EPS
- AWX 0.03
- KPRX N/A
- Revenue
- AWX $78,200,000.00
- KPRX N/A
- Revenue This Year
- AWX N/A
- KPRX N/A
- Revenue Next Year
- AWX N/A
- KPRX N/A
- P/E Ratio
- AWX $82.63
- KPRX N/A
- Revenue Growth
- AWX N/A
- KPRX N/A
- 52 Week Low
- AWX $2.10
- KPRX $2.25
- 52 Week High
- AWX $3.99
- KPRX $4.18
- Technical
- Relative Strength Index (RSI)
- AWX 46.76
- KPRX 46.53
- Support Level
- AWX $2.40
- KPRX $2.58
- Resistance Level
- AWX $2.49
- KPRX $2.80
- Average True Range (ATR)
- AWX 0.04
- KPRX 0.11
- MACD
- AWX 0.00
- KPRX -0.01
- Stochastic Oscillator
- AWX 30.00
- KPRX 21.88
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.